Shopping Cart

No products in the cart.

Dose-dependent effect of megestrol acetate supplementation in cancer patients with anorexia-cachexia syndrome: A meta-analysis.

There is inconsistent evidence relating to the effects of megestrol acetate (MA) supplementation on cancer patients suffering from anorexia-cachexia syndrome. This review aimed to examine the dose-response effect of MA supplementation in patients with cancer-associated anorexia/cachexia.

Relevant keywords were searched in PubMed, Scopus and ISI Web of Science from inception to June 2023 for randomized controlled trials (RCTs) examining the effect of MA on pathologies in patients with cancer-associated cachexia. Our primary outcomes were changes in body weight and appetite.

However, fatigue and quality of life were secondary outcomes. The mean difference (MD) and 95% confidence interval (95% CI) were estimated using the random-effects method.

Thirteen trials comprising 1229 participants (mean age 60ย years) were identified. The results of our highest versus lowest analysis revealed that MA supplementation was not associated with any increase in body weight (MD: 0.64ย kg, 95% CI [-0.11, 1.38], Pย =ย 0.093, Iย =ย 69.1%; GRADEย =ย very low certainty).

Twelve trials, including 14 effect sizes derived from 1369 patients (interventionย =ย 689, controlย =ย 680), provided data on the effect of MA on body weight. Subgroup analyses showed a significant increase in body weight following short-term intervention (โ‰ค8ย weeks) and a combination of radiation/chemotherapy as concurrent treatment.

A linear dose-response meta-analysis indicated that each 200ย mg/day increment in MA consumption had a significant increase in weight gain (MD: 0.44; 95% CI [0.13, 0.74], Pย =ย 0.005; Iย =ย 97.1%); however, the magnitude of the effect was small. MA administration significantly affected the quality of life based on pooled effect sizes (MD: 1.15, 95% CI [0.76, 1.54], Pย <ย 0.001, Iย =ย 0%; nย =ย 2 RCTs including 176 patients; GRADEย =ย very low certainty).

However, no significant effect of MA supplementation was observed on appetite (MD: 0.29, 95% CI [-0.05, 0.64], Pย =ย 0.096, Iย =ย 18.3%; nย =ย 3 RCTs including 163 patients; GRADEย =ย very low certainty) and fatigue (MD: 0.14, 95% CI [-0.09, 0.36], Pย =ย 0.236, Iย =ย 0%; nย =ย 2 RCTs including 300 patients; GRADEย =ย very low certainty). With very low certainty of the evidence, MA supplementation may not lead to a significantly increased weight gain and other outcomes.

Subscribe to the SCWD Newsletter

Stay Informed with the Latest Updates and Exclusive Insights!